Hong Kong Biotech Stocks Continue Strong Performance with Clover Bio-B Surging Over 12%

Deep News

09/01

Hong Kong biotech stocks maintained their upward momentum, with Clover Bio-B leading the gains with a surge of over 12%. Hua Medicine and Alphamab Oncology both climbed more than 9%, while XtalPi Holdings rose over 6%. Junshi Biosciences, WuXi Biologics, and BeiGene all advanced more than 4%.

Pacific Securities released a research note recommending investors pay attention to the incremental impact on the pharmaceutical sector from changes in market pricing power funding, particularly strategic positioning in AI healthcare and innovative drug investment strategies. At the industry level, the firm suggests monitoring: 1) Changes in Federal Reserve interest rate policy, 2) Marginal changes in investment and financing, 3) Gradual recovery in overseas demand, 4) China-US relations and geopolitical factors, 5) The rollout of detailed policies including medical insurance Category C catalog, commercial insurance, and comprehensive support policies for the innovative drug industry chain.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1143376945"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1143376945\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1143376945?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-01 10:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1143376945","market":"us","top_or_hot":-1,"title":"Hong Kong Biotech Stocks Continue Strong Performance with Clover Bio-B Surging Over 12%","media":"Deep News","content":"<p>Hong Kong biotech stocks maintained their upward momentum, with Clover Bio-B leading the gains with a surge of over 12%. Hua Medicine and Alphamab Oncology both climbed more than 9%, while XtalPi Holdings rose over 6%. Junshi Biosciences, WuXi Biologics, and BeiGene all advanced more than 4%.</p>\n<p>Pacific Securities released a research note recommending investors pay attention to the incremental impact on the pharmaceutical sector from changes in market pricing power funding, particularly strategic positioning in AI healthcare and innovative drug investment strategies. At the industry level, the firm suggests monitoring: 1) Changes in Federal Reserve interest rate policy, 2) Marginal changes in investment and financing, 3) Gradual recovery in overseas demand, 4) China-US relations and geopolitical factors, 5) The rollout of detailed policies including medical insurance Category C catalog, commercial insurance, and comprehensive support policies for the innovative drug industry chain.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hong Kong Biotech Stocks Continue Strong Performance with Clover Bio-B Surging Over 12%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHong Kong Biotech Stocks Continue Strong Performance with Clover Bio-B Surging Over 12%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1039043262\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Deep News </p>\n<p class=\"h-time\">2025-09-01 10:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Hong Kong biotech stocks maintained their upward momentum, with Clover Bio-B leading the gains with a surge of over 12%. Hua Medicine and Alphamab Oncology both climbed more than 9%, while XtalPi Holdings rose over 6%. Junshi Biosciences, WuXi Biologics, and BeiGene all advanced more than 4%.</p>\n<p>Pacific Securities released a research note recommending investors pay attention to the incremental impact on the pharmaceutical sector from changes in market pricing power funding, particularly strategic positioning in AI healthcare and innovative drug investment strategies. At the industry level, the firm suggests monitoring: 1) Changes in Federal Reserve interest rate policy, 2) Marginal changes in investment and financing, 3) Gradual recovery in overseas demand, 4) China-US relations and geopolitical factors, 5) The rollout of detailed policies including medical insurance Category C catalog, commercial insurance, and comprehensive support policies for the innovative drug industry chain.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"YANG","symbol_name":"三倍做空富时中国ETF-Direxion","start_time":0,"source_url":"","article_id":"1143376945","we_media_id":"1039043262","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1143376945","pubTimestamp":1756692639,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Deep News","introduction":"Global Stock Market Deep Analysis","home_visible":1,"id":"1039043262","head_image":"https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922"},"summary":"Hong Kong biotech stocks maintained their upward momentum, with Clover Bio-B leading the gains with a surge of over 12%. Hua Medicine and Alphamab Oncology both climbed more than 9%, while XtalPi...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"YANG":"三倍做空富时中国ETF-Direxion","BK1161":"生物科技","HSTECH":"恒生科技指数","BK4614":"Manus概念股","HSCEI":"国企指数","02197":"三叶草生物-B","07226":"南方两倍做多恒科"},"translate_title":"香港生物科技股延续强劲表现三叶草生物-B大涨超12%","themeId":"c3254beb3708cecfea7110f8c44bea74","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02197":1,"HSTECH":1,"YANG":1,"07226":1,"HSCEI":1},"content_text":"Hong Kong biotech stocks maintained their upward momentum, with Clover Bio-B leading the gains with a surge of over 12%. Hua Medicine and Alphamab Oncology both climbed more than 9%, while XtalPi Holdings rose over 6%. Junshi Biosciences, WuXi Biologics, and BeiGene all advanced more than 4%.\nPacific Securities released a research note recommending investors pay attention to the incremental impact on the pharmaceutical sector from changes in market pricing power funding, particularly strategic positioning in AI healthcare and innovative drug investment strategies. At the industry level, the firm suggests monitoring: 1) Changes in Federal Reserve interest rate policy, 2) Marginal changes in investment and financing, 3) Gradual recovery in overseas demand, 4) China-US relations and geopolitical factors, 5) The rollout of detailed policies including medical insurance Category C catalog, commercial insurance, and comprehensive support policies for the innovative drug industry chain.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}